安塔尔制药

ATRS NASDAQ
3.030
+0.070
+2.36%
盘后: 3.030 0 0.00% 16:25 06/17 EDT
开盘
2.960
昨收
2.960
最高
3.070
最低
2.960
成交量
57.09万
成交均量(3M)
80.82万
52周最高
3.960
52周最低
2.455
换手率
0.35%
市值
4.93亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供安塔尔制药 ATRS股票价格,安塔尔制药股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The Company develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs. The Company's subcutaneous injection technology platforms include VIBEX disposable pressure-assisted auto injectors, Vision reusable needle-free injectors and disposable multi-use pen injectors. The Company operates through drug delivery segment, which includes self-administered parenteral pharmaceutical products and technologies. The Company has developed OTREXUP (methotrexate) injection, which is a single dose, disposable auto injector.
展开 >

最近浏览

名称
价格
涨跌幅